Arcus Biosciences, Inc.
US ˙ NYSE ˙ US03969F1093

SecurityRCUS / Arcus Biosciences, Inc.
InstitutionDimensional Fund Advisors Lp
Latest Disclosed Ownership1,426,223 shares
Latest Disclosed Value $ 30,801,780
Dimensional Fund Advisors Lp reports 6.43% decrease in ownership of RCUS / Arcus Biosciences, Inc.

On May 7, 2026 - Dimensional Fund Advisors Lp filed a 13F-HR form disclosing ownership of 1,426,223 shares of Arcus Biosciences, Inc. (US:RCUS) valued at $30,806,417 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 1,524,157 shares of Arcus Biosciences, Inc.. This represents a change in shares of -6.43% during the quarter. The current value of the position is $33,074,111 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F ARCUS BIOSCIENCES COM 03969F109 1,426,223 -97,934 -6.43 30,802 -15.19 0.0014
2026-02-12 2025-12-31 13F ARCUS BIOSCIENCES COM 03969F109 1,524,157 21,694 1.44 36,317 77.75 0.0076
2025-11-12 2025-09-30 13F ARCUS BIOSCIENCES COM 03969F109 1,502,463 -157,416 -9.48 20,432 51.23 0.0044
2025-08-12 2025-06-30 13F ARCUS BIOSCIENCES COM 03969F109 1,659,879 -62,204 -3.61 13,511 -0.07 0.0031
2025-05-13 2025-03-31 13F ARCUS BIOSCIENCES COM 03969F109 1,722,083 19,781 1.16 13,520 -46.67 0.0034
2025-02-13 2024-12-31 13F ARCUS BIOSCIENCES COM 03969F109 1,702,302 178,351 11.70 25,348 8.79 0.0061
2024-11-07 2024-09-30 13F ARCUS BIOSCIENCES COM 03969F109 1,523,951 44,324 3.00 23,301 3.40 0.0057
2024-08-09 2024-06-30 13F ARCUS BIOSCIENCES COM 03969F109 1,479,627 -141,782 -8.74 22,535 -26.39 0.0059
2024-05-10 2024-03-31 13F ARCUS BIOSCIENCES COM 03969F109 1,621,409 26,800 1.68 30,612 0.51 0.0083
2024-02-07 2023-12-31 13F ARCUS BIOSCIENCES COM 03969F109 1,594,609 158,094 11.01 30,459 18.12 0.0089
2023-11-09 2023-09-30 13F ARCUS BIOSCIENCES COM 03969F109 1,436,515 297,035 26.07 25,786 11.43 0.0085
2023-08-09 2023-06-30 13F ARCUS BIOSCIENCES COM 03969F109 1,139,480 -167,597 -12.82 23,141 -2.93 0.0074
2023-05-12 2023-03-31 13F ARCUS BIOSCIENCES COM 03969F109 1,307,077 312,887 31.47 23,839 119,095.00 0.0080
2023-02-09 2022-12-31 13F ARCUS BIOSCIENCES COM 03969F109 994,190 314,096 46.18 21 -99.89 0.0061
2022-11-10 2022-09-30 13F ARCUS BIOSCIENCES COM 03969F109 680,094 359,339 112.03 17,791 118.97 0.0068
2022-08-12 2022-06-30 13F ARCUS BIOSCIENCES COM 03969F109 320,755 -117,214 -26.76 8,125 -41.23 0.0029
2022-05-13 2022-03-31 13F ARCUS BIOSCIENCES COM 03969F109 437,969 190,527 77.00 13,826 38.04 0.0043
2022-02-09 2021-12-31 13F ARCUS BIOSCIENCES COM 03969F109 247,442 208,543 536.11 10,016 638.64 0.0030
2021-11-12 2021-09-30 13F ARCUS BIOSCIENCES COM 03969F109 38,899 4,099 11.78 1,356 41.84 0.0004
2021-08-12 2021-06-30 13F ARCUS BIOSCIENCES COM 03969F109 34,800 34,800 956 0.0003
2021-05-14 2021-03-31 13F ARCUS BIOSCIENCES COM 03969F109 0 -198,754 -100.00 0 -100.00
2021-03-08 2020-12-31 13F/A-2 ARCUS BIOSCIENCES COM 03969F109 198,754 -124,284 -38.47 5,162 -6.77 0.0019
2021-02-11 2020-12-31 13F ARCUS BIOSCIENCES COM 03969F109 198,754 -124,284 5,162 1,864.2400
2020-11-12 2020-09-30 13F ARCUS BIOSCIENCES COM 03969F109 323,038 89,294 38.20 5,537 -4.25 0.0023
2020-08-13 2020-06-30 13F ARCUS BIOSCIENCES COM 03969F109 233,744 -909 -0.39 5,783 77.56 0.0025
2020-05-14 2020-03-31 13F ARCUS BIOSCIENCES COM 03969F109 234,653 45,937 24.34 3,257 70.88 0.0017
2020-02-14 2019-12-31 13F ARCUS BIOSCIENCES COM 03969F109 188,716 120,656 177.28 1,906 207.92 0.0007
2019-11-12 2019-09-30 13F ARCUS BIOSCIENCES COM 03969F109 68,060 68,060 619 0.0002
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.